Literature DB >> 16134000

Vascular endothelial growth factor blockade reduces plasma cytokines in a murine model of polymicrobial sepsis.

Anna Nolan1, Michael D Weiden, Gavin Thurston, Jeffrey A Gold.   

Abstract

Numerous cytokines, including vascular endothelial growth factor (VEGF), are implicated in the pathogenesis of sepsis. While overexpression of VEGF produces pulmonary capillary leak, the role of VEGF in sepsis is less clear. We investigated VEGF in sepsis, utilizing a VEGF trap (VEGF(T)). Polymicrobial sepsis was induced in C57BL/6 mice by cecal ligation and puncture (CLP) and resulted in significantly increased plasma VEGF levels (234 vs. 46 pg/mL; p = 0.03). Inhibition of VEGF had no effect on mortality or lung leak but did attenuate plasma IL-6 (120 vs. 236 ng/mL; p = 0.02) and IL-10 (16 vs. 41 ng/mL; p = 0.03). These alterations in inflammatory cytokines were associated with increased levels of the dominant negative inhibitory C/EBPbeta. In vitro, VEGF stimulated IL-6, IL-10 and reduced the inhibitory isoform of C/EBPbeta in cultured macrophages. Together these data suggest VEGF can regulate inflammatory cytokine production in murine polymicrobial sepsis, via regulation of C/EBPbeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16134000      PMCID: PMC3417046          DOI: 10.1007/s10753-004-6050-3

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  24 in total

1.  The ACCP-SCCM consensus conference on sepsis and organ failure.

Authors:  R C Bone; W J Sibbald; C L Sprung
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

Review 2.  Sepsis and septic shock--a review of laboratory models and a proposal.

Authors:  K A Wichterman; A E Baue; I H Chaudry
Journal:  J Surg Res       Date:  1980-08       Impact factor: 2.192

3.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

4.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

Authors:  E Tischer; R Mitchell; T Hartman; M Silva; D Gospodarowicz; J C Fiddes; J A Abraham
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

5.  Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.

Authors:  D R Senger; D T Connolly; L Van de Water; J Feder; H F Dvorak
Journal:  Cancer Res       Date:  1990-03-15       Impact factor: 12.701

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

7.  High glucose enhances interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in gingival fibroblasts.

Authors:  Kazuhiro Omori; Koji Naruishi; Fusanori Nishimura; Hisa Yamada-Naruishi; Shogo Takashiba
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

8.  CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity.

Authors:  Jeffrey A Gold; Merdad Parsey; Yoshihiko Hoshino; Satomi Hoshino; Anna Nolan; Herman Yee; Doris B Tse; Michael D Weiden
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.

Authors:  Hideko Nakahara; Jian Song; Masamichi Sugimoto; Keisuke Hagihara; Tadamitsu Kishimoto; Kazuyuki Yoshizaki; Norihiro Nishimoto
Journal:  Arthritis Rheum       Date:  2003-06

10.  A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.

Authors:  S Akira; H Isshiki; T Sugita; O Tanabe; S Kinoshita; Y Nishio; T Nakajima; T Hirano; T Kishimoto
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  10 in total

1.  Resveratrol alleviates sepsis-induced acute lung injury by suppressing inflammation and apoptosis of alveolar macrophage cells.

Authors:  Lei Yang; Zhen Zhang; Yuzhen Zhuo; Lihua Cui; Caixia Li; Dihua Li; Shukun Zhang; Naiqiang Cui; Ximo Wang; Hongwei Gao
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

2.  Multiomics of World Trade Center Particulate Matter-induced Persistent Airway Hyperreactivity. Role of Receptor for Advanced Glycation End Products.

Authors:  Syed H Haider; Arul Veerappan; George Crowley; Erin J Caraher; Dean Ostrofsky; Mena Mikhail; Rachel Lam; Yuyan Wang; Maria Sunseri; Sophia Kwon; David J Prezant; Mengling Liu; Ann Marie Schmidt; Anna Nolan
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

3.  Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of sepsis.

Authors:  Subrina Jesmin; Sohel Zaedi; A M Shahidul Islam; S Nusrat Sultana; Yoshio Iwashima; Takeshi Wada; Naoto Yamaguchi; Michiaki Hiroe; Satoshi Gando
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

4.  C/EBP β mRNA expression is upregulated and positively correlated with the expression of TNIP1/TNFAIP3 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.

Authors:  Tian Qian; Yan Chen; Xiaowei Shi; Jian Li; Fei Hao; Dongmei Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

5.  Admission angiopoietin levels in children with septic shock.

Authors:  John S Giuliano; Patrick M Lahni; Kelli Harmon; Hector R Wong; Lesley A Doughty; Joseph A Carcillo; Basilia Zingarelli; Vikas P Sukhatme; Samir M Parikh; Derek S Wheeler
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

6.  Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans.

Authors:  Samir M Parikh; Tadanori Mammoto; Aylit Schultz; Hai-Tao Yuan; David Christiani; S Ananth Karumanchi; Vikas P Sukhatme
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

7.  Combined treatment in punctate inner choroidopathy.

Authors:  Barbara Terelak-Borys; Katarzyna Zagajewska; Irmina Jankowska-Lech; Piotr Tesla; Iwona Grabska-Liberek
Journal:  Ther Clin Risk Manag       Date:  2016-09-23       Impact factor: 2.423

8.  Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: A case-cohort study and murine model of acute particulate exposure.

Authors:  Erin J Caraher; Sophia Kwon; Syed H Haider; George Crowley; Audrey Lee; Minah Ebrahim; Liqun Zhang; Lung-Chi Chen; Terry Gordon; Mengling Liu; David J Prezant; Ann Marie Schmidt; Anna Nolan
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

9.  Therapeutic Potential of Rhododendron arboreum Polysaccharides in an Animal Model of Lipopolysaccharide-Inflicted Oxidative Stress and Systemic Inflammation.

Authors:  Ajaz Ahmad; Adil Farooq Wali; Muneeb U Rehman; Andleeb Khan; Mohammad Raish; Mohsin Kazi; Osamah Alnemer; Padma G M Rao
Journal:  Molecules       Date:  2020-12-21       Impact factor: 4.411

10.  Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.

Authors:  Su Jin Jeong; Sang Hoon Han; Chang Oh Kim; Jun Yong Choi; June Myung Kim
Journal:  Crit Care       Date:  2013-05-27       Impact factor: 9.097

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.